Try our mobile app
Screener

Reviews

2025-03-25
#reports #PMD

[Psychemedics Corporation](https://eninvs.com/all.php?name=PMD) (Diagnostics and Research) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182532)
(2024-11-12, After Market Close):

- Revenue -20% YoY (vs -16.7% in previous quarter and historical rate -8.0%)
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -0.6% vs S&P500 -0.1%
2025-03-25
#reports #DBI

[Designer Brands](https://eninvs.com/all.php?name=DBI) (Apparel Retail) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182509)
(2025-03-20, Before Market Open):

- Revenue -5.3% YoY (vs -1.1% in previous quarter and historical rate +1.4%)
- EBITDA margin -1.4% increased compared to -4.8% same period last year
- Net Debt decreased by $58 mln over the past reporting period (19.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 21.1% of market cap
- EV/EBITDA multiple is 27.6x compared to historical level (75th percentile) of 28.2x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +10.0% vs S&P500 -0.5%
2025-03-25
#reports #BFIN

[BankFinancial Corporation](https://eninvs.com/all.php?name=BFIN) (Banks — Regional) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182500)
(2025-03-24, Before Market Open):

- Revenue 0% YoY (vs -7.7% in previous quarter and historical rate +1.1%)
- Net Income -200% YoY (vs 0.0% in previous quarter and historical rate -4.9%)
- Net Income margin -16.7% decreased compared to 16.7% same period last year
- P/E multiple is 39.8x compared to historical level (75th percentile) of 17.5x
- P/S multiple is 3.2x
- Price to book: 1x

At the opening of the session the share price went down -0.8% vs S&P500 +0.9%
2025-03-23
(review)
Weekly results
for USD strategies

US Leaders: +0.5%

Global Commodities: +3.7%

Trending Ideas: -0.6%

Rising Stars: +2.2%

vs S&P500: +0.5%

2025-03-23
#dividend #WASH

Washington Trust will pay dividends in the amount of 0.56 USD per share on 2025-03-31, which is 1.8% of the current price 31.3. Together with previous payments, the annual dividend yield will be 7.2%

(2025-01-01: 0.56 USD)
(2024-09-30: 0.56 USD)
(2024-06-28: 0.56 USD)
2025-03-23
#dividend #NYMT

New York Mortgage will pay dividends in the amount of 0.2 USD per share on 2025-03-28, which is 2.9% of the current price 6.79. Together with previous payments, the annual dividend yield will be 11.8%

(2024-12-19: 0.2 USD)
(2024-09-27: 0.2 USD)
(2024-06-27: 0.2 USD)
2025-03-23
#dividend #RWAY

Runway Growth Finance Corp. will pay dividends in the amount of 0.36 USD per share on 2025-03-28, which is 3.4% of the current price 10.59. Together with previous payments, the annual dividend yield will be 15.9%

(2024-11-15: 0.4 USD)
(2024-08-09: 0.45 USD)
(2024-05-08: 0.47 USD)
2025-03-23
#dividend #TRIN

Trinity Capital Inc. will pay dividends in the amount of 0.51 USD per share on 2025-03-28, which is 3.2% of the current price 16.14. Together with previous payments, the annual dividend yield will be 12.6%

(2024-12-30: 0.51 USD)
(2024-09-27: 0.51 USD)
(2024-06-27: 0.51 USD)
2025-03-22
#reports #SCHL

[Scholastic](https://eninvs.com/all.php?name=SCHL) (Educational products for children manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182493)
(2025-03-20, After Market Close):

- Revenue +3.4% YoY (vs -3.2% in previous quarter and historical rate +9.9%)
- EBITDA margin 0.9% increased compared to -3.7% same period last year
- EV/EBITDA multiple is 4.6x compared to historical level (75th percentile) of 8.4x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +6.3% vs S&P500 -0.6%
2025-03-22
#reports #AXDX

[Accelerate Diagnostics](https://eninvs.com/all.php?name=AXDX) (Diagnostics and Research) reported for 2024 q4
(2023-11-09, After Market Close):

- Revenue +200% YoY (vs 0.0% in previous quarter and historical rate +17.4%)
- EBITDA margin -133.3% increased compared to -333.3% same period last year
- Net Debt increased by $8 mln over the past reporting period (7.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.8% of market cap
- EV/Sales multiple is 8.9x

At the opening of the session the share price went down -2.4%
2025-03-22
#reports #FORTY

[Formula Systems 1985](https://eninvs.com/all.php?name=FORTY) (Information Technology Services) reported for 2024 q4
(2024-11-20, Before Market Open):

- Revenue +8% YoY (vs +6.9% in previous quarter and historical rate +4.8%)
- EBITDA +85.7% YoY (vs +35.1% in previous quarter and historical rate +30.3%)
- EBITDA margin 3.8% increased compared to 2.2% same period last year
- Net Debt decreased by $88 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) +$0.8 bln (positive), 54.0% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 14.7x
- EV/Sales multiple is 0.6x

2025-03-22
#dividend #MEI

Methode Electronics will pay dividends in the amount of 0.14 USD per share on 2025-04-16, which is 2.1% of the current price 6.68. Together with previous payments, the annual dividend yield will be 8.4%

(2025-01-16: 0.14 USD)
(2024-10-17: 0.14 USD)
(2024-07-11: 0.14 USD)
2025-03-21
#reports #TITN

[Titan Machinery](https://eninvs.com/all.php?name=TITN) (Industrial Distribution) reported for 2024 q4
(2025-03-20, Before Market Open):

- Revenue -10.8% YoY (vs -2.0% in previous quarter and historical rate +25.5%)
- EBITDA -173.5% YoY (vs -59.3% in previous quarter and historical rate +10.3%)
- EBITDA margin -4.7% decreased compared to 5.8% same period last year
- Net Debt increased by $164 mln over the past reporting period (43.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 12.9x compared to historical level (75th percentile) of 5.2x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went down -15.1% vs S&P500 -0.5%
2025-03-21
#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for 2024 q4
(2025-03-20, After Market Close):

- Revenue +5.9% YoY (vs +26.7% in previous quarter and historical rate +37.0%)
- EBITDA margin -44.4% increased compared to -70.6% same period last year
- Net Debt decreased by $35 mln over the past reporting period (60.5% of market cap)
- FCF (LTM) -$0 bln (negative), 50.2% of market cap
- EV/Sales multiple is 0.7x

2025-03-21
#reports #SWKH

[SWK Corporation](https://eninvs.com/all.php?name=SWKH) (Asset Management) reported for 2024 q4
(2025-03-19, After Market Close):

- Revenue +20% YoY (vs +11.1% in previous quarter and historical rate +2.8%)
- P/E multiple is 15.4x compared to historical level (75th percentile) of 41.8x
- P/S multiple is 4.7x
- Price to book: 0.8x

At the opening of the session the share price went down -1.2% vs S&P500 -0.5%
2025-03-21
#reports #RKDA

[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for 2024 q4
(2023-08-10, After Market Close):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +16.0%)
- EBITDA margin 200.0% increased compared to -300.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (101.1% of market cap)
- FCF (LTM) -$0 bln (negative), 151.7% of market cap
- EV/EBITDA multiple is 1.3x compared to historical level (75th percentile) of 0.9x
- EV/Sales multiple is -0.8x

At the opening of the session the share price went up +4.5%
2025-03-21
#reports #DXLG

[Destination XL Group](https://eninvs.com/all.php?name=DXLG) (Apparel Retail) reported for 2024 q4
(2025-03-20, Before Market Open):

- Revenue -13.1% YoY (vs -9.2% in previous quarter and historical rate -2.1%)
- EBITDA -83.3% YoY (vs -11.1% in previous quarter and historical rate -5.2%)
- EBITDA margin 1.7% decreased compared to 8.8% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0 bln (negative), 14.2% of market cap
- EV/EBITDA multiple is 8.6x compared to historical level (75th percentile) of 8.1x
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -10.9% vs S&P500 -0.5%
2025-03-21
#reports #BFRI

[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182461)
(2023-08-11, Before Market Open):

- Revenue +8.8% YoY (vs 0.0% in previous quarter and historical rate +34.6%)
- EBITDA margin -45.9% increased compared to -67.6% same period last year
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -1.9%
2025-03-21
#reports #BBGI

[Beasley Broadcast Group](https://eninvs.com/all.php?name=BBGI) (Broadcasting) reported for 2024 q4
(2024-11-05, Before Market Open):

- Revenue +2.3% YoY (vs -3.2% in previous quarter and historical rate +31.6%)
- EBITDA -4.1% YoY (vs +235300.0% in previous quarter and historical rate +44.7%)
- EBITDA margin 13.9% decreased compared to 14.9% same period last year
- Net Debt decreased by $275.3 bln since the start of the year (148943.3% of market cap)
- FCF (LTM) +$1.8 bln (positive), 988.3% of market cap
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went down -3.0% vs S&P500 +0.1%
2025-03-21
#reports #ARL

[American Realty Investors](https://eninvs.com/all.php?name=ARL) (Real Estate — Development) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=182440)
(2024-03-22, Before Market Open):

- Revenue +157.1% YoY (vs -7.7% in previous quarter and historical rate +23.6%)
- EBITDA -162.5% YoY (vs -50.0% in previous quarter)
- EBITDA margin -13.9% decreased compared to 57.1% same period last year
- EV/Sales multiple is 3.4x

At the opening of the session the share price went down -6.0% vs S&P500 0.0%
2025-03-21
#reports #YI
@ china

[Yi Technology](https://eninvs.com/all.php?name=YI) (Pharmaceutical Retailers) reported for 2024 q4
(2025-03-13, Before Market Open):

- Revenue -9% YoY (vs +2.2% in previous quarter and historical rate +2.9%)
- EBITDA margin 4.6% increased compared to -0.7% same period last year
- Net Debt increased by $24 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0 bln (negative), 3.0% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +2.3% vs S&P500 -0.1%